Tags

Type your tag names separated by a space and hit enter

Experience of 138 Transurethral Urethrotomy With Holmium:YAG Laser.
J Lasers Med Sci 2019; 10(2):104-107JL

Abstract

Introduction: Many valid option modalities are available for the management of urethral stricture disease (USD), such as internal urethrotomy which has the success rates of 33%-60%. The aim of this study was to assess the outcome of holmium: YAG (Ho: YAG) laser urethrotomy (HLU).

Methods:

One hundred thirty-eight patients with urethral stricture with the mean age of 48±3.03 years old treated by HLU from March 2011 to August 2017. The main purpose of this investigation was to evaluate mean operation time, stricture recurrence rate and post-operation Qmax and complications of transurethral HLU.

Results:

The most common cause of USD was trauma in 82 (59.4%) patients. Mean laser operation time, mean hospital stay and mean postoperative duration of catheterization were 23.08 ± 9.1 minutes, 19.02 ± 10.7 hours and 10.3 ± 1.05 days respectively. The mean Qmax was 8.3 ± 2.07 mL/s before surgery and 16 ±3.1 mL/s afterward. At the end of 12 months follow-up, a total of 37 (26.8%) patients developed recurrence of the stricture. Patients with posterior, longer urethral strictures and previous history of interventions have more recurrence rate of the stricture.

Conclusion:

HLU is minimally invasive and seems to be an effective and safe management option for primary, short, urethral strictures. The hospital stay is remarkably short and complications are negligible.

Authors+Show Affiliations

Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Laser Application in Medical Science Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Infertility and Reproductive Health Research Center Shahid Beheshti University of Medical Sciences, Tehran, Iran. Urology Department, Urmia University of Medical Sciences, Urmia, Iran.Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31360378

Citation

Fallah Karkan, Morteza, et al. "Experience of 138 Transurethral Urethrotomy With Holmium:YAG Laser." Journal of Lasers in Medical Sciences, vol. 10, no. 2, 2019, pp. 104-107.
Fallah Karkan M, Razzaghi MR, Karami H, et al. Experience of 138 Transurethral Urethrotomy With Holmium:YAG Laser. J Lasers Med Sci. 2019;10(2):104-107.
Fallah Karkan, M., Razzaghi, M. R., Karami, H., Ghiasy, S., Tayyebiazar, A., & Javanmard, B. (2019). Experience of 138 Transurethral Urethrotomy With Holmium:YAG Laser. Journal of Lasers in Medical Sciences, 10(2), pp. 104-107. doi:10.15171/jlms.2019.17.
Fallah Karkan M, et al. Experience of 138 Transurethral Urethrotomy With Holmium:YAG Laser. J Lasers Med Sci. 2019;10(2):104-107. PubMed PMID: 31360378.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Experience of 138 Transurethral Urethrotomy With Holmium:YAG Laser. AU - Fallah Karkan,Morteza, AU - Razzaghi,Mohammad Reza, AU - Karami,Hossein, AU - Ghiasy,Saleh, AU - Tayyebiazar,Ali, AU - Javanmard,Babak, Y1 - 2019/02/25/ PY - 2019/7/31/entrez PY - 2019/7/31/pubmed PY - 2019/7/31/medline KW - Holmium KW - Internal urethrotomy KW - Laser urethrotomy KW - Urethral stricture KW - YAG laser SP - 104 EP - 107 JF - Journal of lasers in medical sciences JO - J Lasers Med Sci VL - 10 IS - 2 N2 - Introduction: Many valid option modalities are available for the management of urethral stricture disease (USD), such as internal urethrotomy which has the success rates of 33%-60%. The aim of this study was to assess the outcome of holmium: YAG (Ho: YAG) laser urethrotomy (HLU). Methods: One hundred thirty-eight patients with urethral stricture with the mean age of 48±3.03 years old treated by HLU from March 2011 to August 2017. The main purpose of this investigation was to evaluate mean operation time, stricture recurrence rate and post-operation Qmax and complications of transurethral HLU. Results: The most common cause of USD was trauma in 82 (59.4%) patients. Mean laser operation time, mean hospital stay and mean postoperative duration of catheterization were 23.08 ± 9.1 minutes, 19.02 ± 10.7 hours and 10.3 ± 1.05 days respectively. The mean Qmax was 8.3 ± 2.07 mL/s before surgery and 16 ±3.1 mL/s afterward. At the end of 12 months follow-up, a total of 37 (26.8%) patients developed recurrence of the stricture. Patients with posterior, longer urethral strictures and previous history of interventions have more recurrence rate of the stricture. Conclusion: HLU is minimally invasive and seems to be an effective and safe management option for primary, short, urethral strictures. The hospital stay is remarkably short and complications are negligible. SN - 2008-9783 UR - https://www.unboundmedicine.com/medline/citation/31360378/Experience_of_138_Transurethral_Urethrotomy_With_Holmium:YAG_Laser L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31360378/ DB - PRIME DP - Unbound Medicine ER -